Ignite Creation Date:
2025-12-25 @ 12:02 AM
Ignite Modification Date:
2025-12-25 @ 9:59 PM
Study NCT ID:
NCT06610058
Status:
COMPLETED
Last Update Posted:
2024-09-24
First Post:
2024-09-18
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Effects of Instrument Assisted Soft Tissue Mobilization Regarding Range of Motion and Lower Extremity Power
Sponsor:
Beth Marschner
Organization:
Study Overview
Official Title:
Effects of Instrument Assisted Soft Tissue Mobilization on Healthy Tissue Regarding Range of Motion and Lower Extremity Power
Status:
COMPLETED
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
(IASTM)
Brief Summary:
The goal of this clinical trial is to study the effects of instrument assisted soft tissue mobilization (IASTM) in healthy adult volunteers. The main questions it aims to answer are:
* Does IASTM treatment have an effect on range of motion (ROM) as measured in the hip, knee and ankle?
* Does IASTM treatment have an effect on lower extremity power? Researchers will compare pre-test and post-test IASTM treatment intervention data to the pre-test and post-test data of the no treatment control intervention to see if IASTM works to change range of motion and/or lower extremity power.
Participants will:
* Complete a questionnaire on medical history and injury background
* Have hip, knee and ankle range of motion (ROM) measurements taken on both lower extremities using a goniometer
* Complete three trials of vertical jump testing using a Fleage Floor standing vertical jump measurement tester with one warm up first
* Complete three trials of horizontal jump testing using a Woanger 12'x2.5' long jump mat and verified by a secondary measure using a tape measure with one warm up first
* Be randomly assigned to either IASTM first treatment group or the wait/control first group
* Receive IASTM treatment techniques including application of emollient to the skin to reduce friction on the surface followed by scanning the hamstrings, quadriceps, gastroc/soleus complex, and Achilles tendon using the HG8-Scanner tool for 15 strokes in each direction. Then the concave tool corresponding to the size of the structure being treated will be used (HG6-Large Multi-Curve, HG5-Medium Multi-Curve, HG4-Small Multi-Curve) for 15 strokes in each direction.
* Simply wait for 20 minutes (the duration of time treatment with IASTM would require) when completing the control treatment.
* Complete hip, knee and ankle range of motion and vertical and horizontal jump measure testing at the end of the first session.
* Return within fourteen days after the first session in order to undergo the opposite experience (IASTM first means wait/control second and vice versa).
* Undergo the same baseline pre-test measurements for range of motion and vertical and horizontal jump measure testing as the first session.
* Experience the opposite treatment for the same time period as the first session.
* Undergo the post-test range of motion and vertical and horizontal jump measure testing at the end of the second session for data comparison.
* Does IASTM treatment have an effect on range of motion (ROM) as measured in the hip, knee and ankle?
* Does IASTM treatment have an effect on lower extremity power? Researchers will compare pre-test and post-test IASTM treatment intervention data to the pre-test and post-test data of the no treatment control intervention to see if IASTM works to change range of motion and/or lower extremity power.
Participants will:
* Complete a questionnaire on medical history and injury background
* Have hip, knee and ankle range of motion (ROM) measurements taken on both lower extremities using a goniometer
* Complete three trials of vertical jump testing using a Fleage Floor standing vertical jump measurement tester with one warm up first
* Complete three trials of horizontal jump testing using a Woanger 12'x2.5' long jump mat and verified by a secondary measure using a tape measure with one warm up first
* Be randomly assigned to either IASTM first treatment group or the wait/control first group
* Receive IASTM treatment techniques including application of emollient to the skin to reduce friction on the surface followed by scanning the hamstrings, quadriceps, gastroc/soleus complex, and Achilles tendon using the HG8-Scanner tool for 15 strokes in each direction. Then the concave tool corresponding to the size of the structure being treated will be used (HG6-Large Multi-Curve, HG5-Medium Multi-Curve, HG4-Small Multi-Curve) for 15 strokes in each direction.
* Simply wait for 20 minutes (the duration of time treatment with IASTM would require) when completing the control treatment.
* Complete hip, knee and ankle range of motion and vertical and horizontal jump measure testing at the end of the first session.
* Return within fourteen days after the first session in order to undergo the opposite experience (IASTM first means wait/control second and vice versa).
* Undergo the same baseline pre-test measurements for range of motion and vertical and horizontal jump measure testing as the first session.
* Experience the opposite treatment for the same time period as the first session.
* Undergo the post-test range of motion and vertical and horizontal jump measure testing at the end of the second session for data comparison.
Detailed Description:
No further information to note than what is described in the summary or elsewhere
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?: